Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > Cannabidiol (CBD) Market
Cannabidiol Market size was valued at USD 22.8 billion in 2023 and is anticipated to witness growth at a CAGR of 17.9% between 2024 and 2032. Increasing consumer awareness and acceptance of CBD products for their potential health benefits, including pain relief, anxiety reduction, and improved sleep quality, is a significant driver.
Additionally, legalization of hemp-derived CBD in various regions has expanded market opportunities, allowing for the development and distribution of a wide range of products such as cannabidiol oil, edibles, and topicals. Moreover, advancements in extraction and processing technologies have also enhanced product quality and consistency, further boosting consumer confidence. Furthermore, the increasing number of clinical trials and scientific studies supporting the efficacy and safety of CBD contributes to its credibility and adoption. Lastly, the expansion of e-commerce platforms has made CBD products more accessible, driving sales and market penetration globally.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Cannabidiol Market Size in 2023: | USD 22.8 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 17.9% |
2032 Value Projection: | USD 108 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 340 |
Tables, Charts & Figures: | 583 |
Segments covered: | Source, Product, Application, Route of Administration, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Cannabidiol (CBD) is a chemical compound obtained from marijuana and hemp plants and is commonly used for medical purposes. Cannabidiol (CBD) is used for treating pain, anxiety, muscle disorder (dystonia), Crohn disease, Parkinson disease and many other medical conditions. Hence, cannabidiol is gaining widespread popularity across regions.